India to Myanmar: Chlorambucil Export Trade Route
India has recorded 6 verified shipments of Chlorambucil exported to Myanmar, representing a combined trade value of $8.4K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $1.4K USD. The leading Indian exporter is DECINA PHARMA PRIVATE LIMITED, which accounts for 81% of total export value with 3 shipments worth $6.8K USD. On the buying side, IMPERIAL PHOENIX is the largest importer in Myanmar with $6.8K USD in purchases. The top 3 suppliers — DECINA PHARMA PRIVATE LIMITED, INFUGEN LIFE SCIENCES PRIVATE LIMITED, MBA PHARMACEUTICALS PRIVATE LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Chlorambucil corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $8.4K USD. The route is dominated by DECINA PHARMA PRIVATE LIMITED, which alone accounts for roughly 81% of all export value, reflecting the consolidated nature of India's chlorambucil manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $1.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 33.0%, placing it at rank #13 among India's top chlorambucil export destinations globally.
On the import side, key buyers of Indian chlorambucil in Myanmar include IMPERIAL PHOENIX, PHARMA APEX COMPANY LTD., THE MANAGER- BBJ CO LIMITED and 1 others. IMPERIAL PHOENIX is the single largest importer with 3 shipments valued at $6.8K USD.
Route Characteristics
- Average transit
